BioNTech SE (LON:0A3M)
87.00
-1.16 (-1.32%)
At close: Nov 10, 2026
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
265.18K GBP
Profits / Employee
-161.41K GBP
Market Cap
16.16B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genus | 2,921 |
| Oxford Nanopore Technologies | 1,314 |
| Oxford Biomedica | 1,017 |
| 4basebio | 140 |
| PureTech Health | 90 |
| Avacta Group | 81 |
| Scancell Holdings | 55 |
| Faron Pharmaceuticals Oy | 36 |
BioNTech SE News
- 1 day ago - BioNTech price target lowered to $110 from $130 at H.C. Wainwright - TheFly
- 6 days ago - BioNTech price target lowered to $106 from $114 at Morgan Stanley - TheFly
- 6 days ago - BioNTech price target lowered to $108 from $114 at BofA - TheFly
- 6 days ago - BioNTech price target lowered to $125 from $135 at UBS - TheFly
- 7 days ago - BioNTech SE Earnings Call Transcript: Q3 2026 - Transcripts
- 7 days ago - BioNTech SE Earnings release: Q3 2026 - Filings
- 7 days ago - BioNTech SE Slides: Q3 2026 - Filings
- 7 days ago - BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update - GlobeNewsWire